Sanofi | SAN - Zahlungsmittel Und Äquivalente

Aktienkurs
80.08
Täglich Wechseln
-1.68 -2.05%
Monatlich
-1.32%
Jährlich
-13.99%
Q2 Prognose
78.25




Zahlungsmittel Und Äquivalente Veränderung Datum
AbbVie USD 5.23B 400M 2025-12
Aena EUR 950.33M 1.29B 2025-06
Alcon AG USD 1.5B 90M 2025-09
Almirall EUR 337.77M 14.83M 2025-12
Amarin USD 122.8M 25.08M 2025-09
Amgen USD 9.13B 316M 2025-12
AstraZeneca USD 8.14B 1.08B 2025-09
Bayer EUR 5.9B 1.34B 2025-09
Biogen USD 3.01B 854.3M 2025-12
BMW EUR 18.85B 2.83B 2025-12
Bristol-Myers Squibb USD 10.21B 5.52B 2025-12
Eli Lilly USD 7.27B 2.52B 2025-12
Essilor EUR 3.54B 758M 2025-12
Fresenius EUR 1.23B 1.16B 2025-06
Fresenius Medical Care EUR 1.58B 326.57M 2025-12
Galapagos EUR 87.87M 23.41M 2025-12
Genmab DKK 1.72B 46M 2025-12
Gilead Sciences USD 7.56B 234M 2025-12
GlaxoSmithKline GBP 3.3B 303M 2025-09
GRIFOLS EUR 558.69M 194.13M 2025-06
Hikma Pharmaceutical USD 236M 48M 2025-06
J&J USD 21.69B 1.98B 2026-03
Lonza CHF 719M 188M 2025-12
Mercedes-Benz AG EUR 11.91B 2.03B 2025-09
Merck EUR 2.25B 1.08B 2025-09
Merck USD 18.17B 10.16B 2025-09
Novartis USD 9.56B 2.9B 2025-09
Novo Nordisk A/S DKK 18.44B 5.78B 2025-06
Orion EUR 160.9M 63.3M 2025-12
Pfizer USD 1.34B 295M 2025-09
Philips EUR 1.91B 90M 2025-09
Recordati EUR 471.46M 129.91M 2025-09
Regeneron Pharmaceuticals USD 18.87B 16.36B 2025-12
Roche Holding CHF 7.55B 579M 2025-06
Sanofi EUR 7.66B 1.25B 2025-12
Sanofi EUR 7.66B 1.25B 2025-12
SAP EUR 10.04B 1.83B 2026-03
UCB EUR 1.57B 1.14B 2024-12
Vinci EUR 17.25B 2.18B 2025-12
Volkswagen EUR 36.87B 118M 2025-09